Josh Kaufman


My clients turn to me as a trusted advisor in critical financing and corporate transactions.

+1 212 479 6495

Josh Kaufman's practice focuses on capital markets transactions, primarily in the life sciences and technology verticals. He represents US and foreign private issuers and underwriters in a wide variety of public offerings and private placements. Josh has advised clients on more than 200 financing transactions with an aggregate value in excess of $100 billion. He also counsels clients with respect to public company and corporate governance matters; general corporate and commercial matters; mergers & acquisitions and other strategic transactions; and dealings with securityholders, securities exchanges and regulatory bodies.

Download full bio 


  • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab 

  • COMPASS Pathways – $147 Million IPO 

  • PolyPid – $69 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • Bavarian Nordic - DKK$2.7 Billion Rights Issue 

  • View all


  • Columbia University School of Law
    JD, 2002

  • Columbia University Graduate School of Business
    MBA, 2002

  • Harvard University
    AB, 1998

Admissions & Credentials

New York


+1 212 479 6495 office
+1 347 438 3009 fax

55 Hudson Yards
New York, NY 10001-2157